All lipid levels except ApoA1 at baseline differed as a function of mortality status at follow‐up in men and women (all P < 0.01, Table S3); this was the case for all lipids when examined as a function of CHD at follow‐up in men and women (all P < 0.001, Table S4). This evidence concerns the gene APOA1 and coronary artery disorder.